Glucose, Understanding, Integrated Digital Health, and Engagement (GUIDE) Study
Key facts
- Where
- New Haven, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Source: NCT07689877, who can take part
Where in United States
- Yale School of NursingNew Haven, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Yale University
- Trial code
- NCT07689877
- Record updated
- 29 September 2026
- Original description
The purpose of this study is to evaluate whether an Integrated Digital Health (IDH) intervention with and without healthcare provider engagement, improves glycemic control and diabetes-related outcomes among adults with Type 2 diabetes. The study will also assess the feasibility of integrating this approach into routine primary care to support personalized, data-informed diabetes management.Read full original descriptionShow less
The purpose of this study is to evaluate whether an Integrated Digital Health (IDH) intervention with and without healthcare provider engagement, improves glycemic control and diabetes-related outcomes among adults with Type 2 diabetes. The study will also assess the feasibility of integrating this approach into routine primary care to support personalized, data-informed diabetes management.
Inclusion: diagnosis of T2D for at least one year; recent 3 month-HbA1c, 8-11%; ownership of a smartphone; English or Spanish speaking.
Exclusion: serious medical conditions or active thought disorders (e.g., terminal cancer, schizophrenia); In addition to the self-report of the HbA1c within the past 3 months, potential participants will be screened with a point-of-care (POC) HbA1c (A1CNow®+); pregnant; not available or willing to use CGM or study device/platform.